Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated omega-3 fatty acids for advanced cancer patients with significant weight loss; the study has comp…
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: EBUS-TBNA Versus EBUS-TBNB [NA]
A clinical trial comparing EBUS-TBNA to EBUS-TBNB has been withdrawn from the registry, per the sponsor Royal Brompton & Harefield NHS Found…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies [Phase 1]
Phase 1 study of idelalisib (IPI-145) in combination with Rituximab or Bendamustine/Rituximab in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment [Phase 3]
Phase 3 trial evaluating ondansetron for chronic nausea and vomiting in patients with advanced cancer not caused by cancer treatment; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [NA]
This terminated clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation followed by cyc…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating SL-11047 in patients with relapsed or refractory lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy [Phase 4]
This is a Phase 4 clinical trial update for PEG-rhG-CSF in patients with lymphoma receiving chemotherapy. The study has completed.
-
CLINICAL_TRIALS research · 2016-06-16Clinical Trial Update: Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization [NA]
A completed clinical trial evaluating the impact of socio-aesthetic care on quality of life in lymphoma patients during and after hospitaliz…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Phase 1]
Phase 1 trial evaluating a conditioning regimen of gemcitabine, busulfan, and melphalan with hematopoietic cell transplantation for advanced…
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: An Open Label Dose Escalation Study Of E7080 [Phase 1]
Open-label Phase 1 dose-escalation trial of E7080 (lenvatinib) in solid tumors and lymphomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: RTA 744 Injection in Patients With Leptomeningeal Disease [Phase 1]
Phase 1 trial of RTA 744 injection for leptomeningeal disease in patients with neoplastic meningitis and other CNS/solid tumors has been ter…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Phase I Study of Sequential Cord Blood Transplants [Phase 1]
Phase I study of sequential cord blood transplants has completed enrollment for conditions including lymphoma, leukemia, multiple myeloma, a…
-
CLINICAL_TRIALS guidance · 2016-05-06Clinical Trial Update: PERCIST Criteria for Response Evaluation With Solid Tumors
This document provides an update on PERCIST criteria for PET-based response evaluation in solid tumors, outlining how response endpoints may…
-
CLINICAL_TRIALS withdrawal · 2016-05-04Clinical Trial Update: Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating belinostat in combination with azacitidine, gemcitabine, busulfan, and melphalan with autologous stem-cell tran…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Korean Post-marketing Surveillance for Sprycel®
This is a completed Korean post-marketing surveillance study of Sprycel (dasatinib). It covered patients with chronic myelomonocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202
Completed trial update analyzing dendritic cell phenotype and function in patients treated with VEGF-Trap (aflibercept) in VGFT-ST-0202. The…
-
CLINICAL_TRIALS research · 2016-04-12Clinical Trial Update: MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma [NA]
A clinical trial update evaluating MRI versus PET/CT for staging and treatment response assessment in lymphoma.
-
CLINICAL_TRIALS withdrawal · 2016-03-21Clinical Trial Update: Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants [Phase 1]
A Phase 1 trial of immunotherapy for Epstein-Barr virus–associated lymphoproliferative diseases in organ transplant recipients was withdrawn…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) [Phase 2]
A Phase 2 study evaluating donor lymphocyte infusion after allogeneic stem cell transplantation in leukemia and lymphoma was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia [Phase 2]
Phase 2 study of the investigational agent SAR245409 in lymphoma has been completed.
-
CLINICAL_TRIALS withdrawal · 2016-03-11Clinical Trial Update: Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating lamivudine and tenofovir for lymphoma has been withdrawn.